Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy »

Stanford Health Care

Update to 'A Contemporary Systematic Review on Liver Transplantation for Unresectable Liver Metastasis of Colorectal Cancer'. Annals of surgical oncology Wehrle, C. J., Fujiki, M., Schlegel, A., Whitsett Linganna, M., Pita, A., Kim, J. K., Kwon, D. C., Miller, C., Hashimoto, K., Dueland, S., Sasaki, K., Sapisochin, G., Line, P. D., Hernandez-Alejandro, R., Aucejo, F. 2023

Abstract

Colorectal cancer is the second most common cause of cancer-related death worldwide, and half of patients present with colorectal liver metastasis (CRLM). Liver transplant (LT) has emerged as a treatment modality for otherwise unresectable CRLM. Since the publication of the Lebeck-Lee systematic review in 2022, additional evidence has come to light supporting LT for CRLM in highly selected patients. This includes reports of >10-year follow-up with over 80% survival rates in low-risk patients. As these updated reports have significantly changed our collective knowledge, this article is intended to serve as an update to the 2022 systematic review to include the most up-to-date evidence on the subject.

View details for DOI 10.1245/s10434-023-14611-z

View details for PubMedID 37996635

View details for PubMedCentralID 3481888